Introduction
Angiosarcoma is a rare soft tissue tumor that accounts for only 2% of sarcomas [1] . It originates from vascular and lymphatic endothelium and most commonly arises in the head, neck, and breast [2] . In this report, we present an unusual presentation of a primary perirenal angiosarcoma.
Case report
A 65-year-old male presented to his primary care physician with a 6-month history of left flank pain and an unintentional 20-pound weight loss. His prior medical history was notable for a 30-pack year smoking history, but was otherwise unremarkable. He was anemic with a hematocrit of 30.5 (reference range 41.0%-53.0%), but his hemoglobin was 13 g/dL (reference range: 13.5-17.5 g/dL) and his serum creatinine was 0. Because of the history of an atrophic right kidney and the desire to avoid a left nephrectomy and the subsequent need for long-term hemodialysis, the patient was treated with Taxotere followed by proton beam therapy (18 Gy). One month later ( Fig. 2 ) 
Discussion
Perirenal angiosarcoma is an exceedingly rare malignant neoplasm [3] . Most reported cases of renal angiosarcoma represent metastasis from other sites [4] . Very few cases of renal angiosarcoma have been reported in the literature [5] .
Primary renal angiosarcomas often occur in 6th decade of life with predilection for men [6, 7] . Risk factors for renal angiosarcoma have not yet been identified; however, exposure to radiation and vinyl chloride are known risk factors for soft tissue and hepatic angiosarcomas [8, 9] .
Early diagnosis is challenging because clinical symptoms often develop when tumor has metastasized to other organs [3] . Radiologic imaging alone cannot provide sufficient information for diagnosis. CT findings widely vary for this condition, they can present as heterogenous mass, as in our case, or a hypodense mass with areas of enhancement [ 6 ,10 ] . Diagnosis is only possible after immunohistochemical staining. The most commonly used markers are CD-31, CD-34 which are endothelial adhesion molecule and a human hematopoietic progenitor cell antigen [ 11 ,12 ] .
Because of their rarity, there is no standard therapy for these tumors. While nephrectomy is often performed in most reported cases [6] , this case demonstrates the clinical effectiveness of neoadjuvant chemoradiation prior to renal preserving resection of the mass.
